AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 20
- Registration Number
- NCT00690404
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 60
- Registration Number
- NCT00689780
- Locations
- 🇸🇪
Research Site, Upssala, Sweden
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 69
- Registration Number
- NCT00690079
- Locations
- 🇬🇧
Research Site, Macclesfield, Cheshire, United Kingdom
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2010-12-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 576
- Registration Number
- NCT00690365
Depressive Symptoms in Acute Manic Episode
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2010-12-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 250
- Registration Number
- NCT00690248
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2015-08-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 130
- Registration Number
- NCT00688779
- Locations
- 🇸🇪
Research Site, Lund, Sweden
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 49
- Registration Number
- NCT00688714
Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2013-01-31
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 5103
- Registration Number
- NCT00688532
Effects of Single Oral Dose Dapagliflozin QT Study
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2012-03-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT00688493
- Locations
- 🇺🇸
Research Site, Baltimore, Maryland, United States
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
Completed
- Conditions
- Hypercholesteremia
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2009-04-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3392
- Registration Number
- NCT00688454
© Copyright 2025. All Rights Reserved by MedPath